연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
2051. Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.
Lee DW, Han SW, Cha Y, Bae JM, Kim HP, Lyu J, Han H, Kim H, Jang H, Bang D, Huh I, Park T, Won JK, Jeong SY, Park KJ, Kang GH, Kim TY
Cancer. 2017 Sep 15;123(18):3513-3523
Link
2050. The Potential Roles of Radionanomedicine and Radioexosomics in Prostate Cancer Research and Treatment.
Bakht MK, Oh SW, Hwang DW, Lee YS, Youn H, Porter LA, Cheon GJ, Kwak C, Lee DS, Kang KW.
Curr Pharm Des. 2017;23(20):2976-2990. doi: 10.2174/1381612823666170216122412.
Link
2049. STAT3 activation in endothelial cells is important for tumor metastasis via increased cell adhesion molecule expression.
Kim KJ, Kwon SH, Yun JH, Jeong HS, Kim HR, Lee EH, Ye SK, Cho CH
Oncogene. 2017 Sep 28;36(39):5445-5459. doi: 10.1038/onc.2017.148. Epub 2017 May 22.
Link
2048. Screening of Pro-Asp Sequences Exposed on Bacteriophage M13 as an Ideal Anchor for Gold Nanocubes
Lee HK, Lee Y, Kim H, Lee HE, Chang H, Nam KT, Jeong DH, Chung J
ACS Synth Biol. 2017 Sep 15;6(9):1635-1641. doi: 10.1021/acssynbio.7b00106. Epub 2017 Jun 8.
Link
2047. Anti-complement component 5 antibody targeting MG4 domain inhibits choroidal neovascularization.
Jo DH, Kim JH, Yang W, Kim H, Chang S, Kim D, Chang M, Lee K, Chung J, Kim JH
Oncotarget., 2017 Jul 11;8(28):45506-45516.
Link
2046. Next-generation sequencing enables the discovery of more diverse positive clones from a phage-displayed antibody library.
Yang W, Yoon , Lee S, Kim S, Han J, Chung J
Exp Mol Med. 2017 Mar 24;49(3):e308. doi: 10.1038/emm.2017.22.
Link
2045. A point mutation in the heavy chain complementarity-determining region 3 (HCDR3) significantly enhances the specificity of an anti-ROS1 antibody
Lee HK, Jin J, Kim SI, Kang MJ, Yi EC, Kim JE, Park JB, Kim H, Chung J
Biochem Biophys Res Commun. 2017 Nov 4;493(1):325-331. doi: 10.1016/j.bbrc.2017.09.023. Epub 2017 Sep 6.
Link
2044. Preclinical development of a humanized neutralizing antibody targeting HGF.
Kim H, Hong SH, Kim JY, Kim IC, Park YW, Lee SJ, Song SW, Kim JJ, Park G, Kim TM, Kim YH, Park JB, Chung J, Kim IH.
Exp Mol Med. 2017 Mar 24;49(3):e309. doi: 10.1038/emm.2017.21.
Link
2043. Discrepancy Between Tumor Antigen Distribution and Radiolabeled Antibody Binding in a Nude Mouse Xenograft Model of Human Melanoma.
Kim YI, Paeng JC, Cheon GJ, Kang KW, Lee DS, Chung JK
Cancer Biother Radiopharm. 2017 Apr;32(3):83-89. doi: 10.1089/cbr.2016.2115. Epub 2017 Apr 5.
Link
2042. Preclinical anaylses of [18F]cEFQ as a PET tracer for imaging metabotropic glutamate receptor type 1 (mGluR1).
Lee B, Kim YK, Lee JY, Kim YJ, Lee YS, Lee DS, Chung JK, Jeong JM
J Cereb Blood Flow Metab. 2017 Jun;37(6):2283-2293. doi: 10.1177/0271678X16663948. Epub 2016 Jan 1.
Link